Integrated BioPharma, Inc. (INBP) short interest & options flow
OTCPKIntegrated BioPharma heads into the week with a share price of $0.265 and an ownership structure so concentrated that conventional short-side pressure is almost irrelevant. The ownership picture is the defining feature here. Damon DeSantis holds 41.6% of the company outright, a position reported as recently as April 15. The DeSantis family and affiliated estates collectively…
- Market cap
- $5M
- Next earnings
- 17 Nov 2026
Key data as of 12 Nov 2026

INBP news and analysis
RSSNo long-form analysis yet for INBP. Pulse alerts and the live data picture are available on ORTEX.
Open INBP on ORTEX →Want the live picture for INBP?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INBP — free to start on ORTEX.
Sign up for free →Open INBP on ORTEX